2020
DOI: 10.1016/j.amjms.2020.07.011
|View full text |Cite
|
Sign up to set email alerts
|

When and How to Diagnose Fabry Disease in Clinical Pratice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
37
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(40 citation statements)
references
References 96 publications
0
37
0
3
Order By: Relevance
“…In FD women usually have a milder disease course than men, which is due to a random inactivation of the X chromosome. However, severe involvement of such target organs as the heart or kidneys is quite common (18). Despite residual enzyme activity, women with FD develop characteristic symptoms with age, including central nervous system symptoms.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In FD women usually have a milder disease course than men, which is due to a random inactivation of the X chromosome. However, severe involvement of such target organs as the heart or kidneys is quite common (18). Despite residual enzyme activity, women with FD develop characteristic symptoms with age, including central nervous system symptoms.…”
Section: Resultsmentioning
confidence: 99%
“…Lyso-Gb3 levels in women increase with age and are within the normal range in childhood. However, when symptomatic FD is suspected in adult women, both measurement of α-Gal A and plasma lyso-Gb3 activity improves the diagnostic value (18).…”
Section: Wwwirdrjournalcommentioning
confidence: 99%
“…Other limitations to best corrected visual acuity in patients with Fabry disease include anterior subcapsular cataract, posterior subcapsular cataract (also known as a Fabry cataract), and corneal haze [ 13 ]. Fabry disease can also be associated with retinal vessel tortuosity, though vessel wall integrity is usually preserved.…”
Section: Key Summary Pointsmentioning
confidence: 99%
“…Currently, measuring α-GAL A enzyme activity in plasma and genetic testing are the most common Fabry disease screening methods in clinical labs [21] , [22] , [23] , [24] . The heterogeneity between patients, even those having the same Fabry mutation, has been a considerable issue for Fabry patients’ diagnosis, especially for patients with some residual enzyme activity and patients with unknown mutations [25] .…”
Section: Introductionmentioning
confidence: 99%